• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童感染 COVID-19 后心脏风险有多大?儿科风险评估;超声心动图和心电图的见解。

How safe are children with COVID-19 from cardiac risks? Pediatric risk assesment; insights from echocardiography and electrocardiography.

机构信息

Department of Pediatric Cardiology, Marmara University School of Medicine, İstanbul, Turkey

Department of Pediatric Infection Disease, Marmara University School of Medicine, İstanbul, Turkey

出版信息

Turk J Med Sci. 2021 Jun 28;51(3):981-990. doi: 10.3906/sag-2010-240.

DOI:10.3906/sag-2010-240
PMID:33517608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8283426/
Abstract

BACKGROUND/AIM: Approximately 40 million individuals worldwide have been infected with SARS-CoV-2, the virus responsible for the novel coronavirus disease-2019 (COVID-19). Despite the current literature about the cardiac effects of COVID-19 in children, more information is required. We aimed to determine both cardiovascular and arrhythmia assessment via electrocardiographic and echocardiographic parameters.

MATERIALS AND METHODS

We evaluated seventy children who were hospitalized with COVID-19 infections and seventy children as normal control group through laboratory findings, electrocardiography (ECG), and transthoracic echocardiography (TTE).

RESULTS

We observed significantly increased levels of Tp-Te, Tp-Te/QT, and Tp-Te/QTc compared with the control group. Twenty-five of 70 (35.7%) patients had fragmented QRS (fQRS) without increased troponin levels. On the other hand, none of the patients had pathologic corrected QT(QTc) prolongation during the illness or its treatment. On TTE, 20 patients had mild mitral insufficiency, among whom only five had systolic dysfunction (ejection fraction < 55%). There was no significant difference between the patient and control groups, except for isovolumic relaxation time (IVRT) in terms of mean systolic and diastolic function parameters. IVRT of COVID patients was significantly lower than that of control group.

CONCLUSION

Despite all the adult studies, the effects of COVID‐19 on myocardial function are not well established in children. The thought that children are less affected by the illness may be a misconception.

摘要

背景/目的:全球约有 4000 万人感染了导致 2019 年新型冠状病毒病(COVID-19)的 SARS-CoV-2 病毒。尽管目前有关于 COVID-19 对儿童心脏影响的文献,但仍需要更多信息。我们旨在通过心电图和超声心动图参数来确定心血管和心律失常的评估。

材料和方法

我们通过实验室检查、心电图(ECG)和经胸超声心动图(TTE)评估了 70 名因 COVID-19 感染住院的儿童和 70 名正常对照组儿童。

结果

与对照组相比,我们观察到 Tp-Te、Tp-Te/QT 和 Tp-Te/QTc 水平显著升高。70 例患者中有 25 例(35.7%)存在碎裂 QRS(fQRS),而无肌钙蛋白水平升高。另一方面,在疾病或其治疗过程中,没有患者出现病理性校正 QT(QTc)延长。在 TTE 上,20 例患者有轻度二尖瓣关闭不全,其中只有 5 例有收缩功能障碍(射血分数<55%)。除等容舒张时间(IVRT)外,患者组和对照组在平均收缩和舒张功能参数方面没有显著差异。COVID 患者的 IVRT 明显低于对照组。

结论

尽管有所有的成人研究,但 COVID-19 对儿童心肌功能的影响尚未得到充分证实。认为儿童受疾病影响较小可能是一种误解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0025/8283426/1ce985925687/turkjmedsci-51-981-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0025/8283426/10df4745bee4/turkjmedsci-51-981-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0025/8283426/0ebcf93fa32a/turkjmedsci-51-981-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0025/8283426/1ce985925687/turkjmedsci-51-981-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0025/8283426/10df4745bee4/turkjmedsci-51-981-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0025/8283426/0ebcf93fa32a/turkjmedsci-51-981-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0025/8283426/1ce985925687/turkjmedsci-51-981-fig003.jpg

相似文献

1
How safe are children with COVID-19 from cardiac risks? Pediatric risk assesment; insights from echocardiography and electrocardiography.儿童感染 COVID-19 后心脏风险有多大?儿科风险评估;超声心动图和心电图的见解。
Turk J Med Sci. 2021 Jun 28;51(3):981-990. doi: 10.3906/sag-2010-240.
2
Determining Which Hospitalized Coronavirus Disease 2019 Patients Require Urgent Echocardiography.确定哪些住院的 2019 冠状病毒病患者需要紧急超声心动图检查。
J Am Soc Echocardiogr. 2021 Aug;34(8):831-838. doi: 10.1016/j.echo.2021.03.010. Epub 2021 Apr 1.
3
Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19.新诊断的COVID-19患者心电图心室复极变量的评估。
J Electrocardiol. 2020 Sep-Oct;62:5-9. doi: 10.1016/j.jelectrocard.2020.07.005. Epub 2020 Jul 21.
4
Effect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019.三联抗微生物疗法对轻至中度 2019 冠状病毒病患者心电图参数的影响。
Anatol J Cardiol. 2021 Mar;25(3):184-190. doi: 10.14744/AnatolJCardiol.2020.79138.
5
De-novo development of fragmented QRS during a six-month follow-up period in patients with COVID-19 disease and its cardiac effects.在 COVID-19 患者六个月的随访期间,出现碎裂 QRS 波的新发病变及其心脏影响。
J Electrocardiol. 2022 May-Jun;72:44-48. doi: 10.1016/j.jelectrocard.2022.02.012. Epub 2022 Mar 12.
6
Characteristics of Cardiac Injury in Critically Ill Patients With Coronavirus Disease 2019.新型冠状病毒 2019 危重症患者的心脏损伤特征。
Chest. 2021 May;159(5):1974-1985. doi: 10.1016/j.chest.2020.10.056. Epub 2020 Oct 28.
7
Characterization of Myocardial Injury in Patients With COVID-19.新型冠状病毒肺炎患者心肌损伤特征。
J Am Coll Cardiol. 2020 Nov 3;76(18):2043-2055. doi: 10.1016/j.jacc.2020.08.069.
8
The relationship between severe acute respiratory syndrome coronavirus 2 (SARS - COV - 2) pandemic and fragmented QRS.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行与碎裂QRS波之间的关系
J Electrocardiol. 2020 Sep-Oct;62:10-13. doi: 10.1016/j.jelectrocard.2020.07.009. Epub 2020 Jul 22.
9
Indications for and Findings on Transthoracic Echocardiography in COVID-19.COVID-19 经胸超声心动图的适应证和发现。
J Am Soc Echocardiogr. 2020 Oct;33(10):1278-1284. doi: 10.1016/j.echo.2020.06.009. Epub 2020 Jun 17.
10
Does Iron Deficiency Affect the Heart in Children?缺铁是否会影响儿童的心脏?
J Pediatr Hematol Oncol. 2022 Apr 1;44(3):84-88. doi: 10.1097/MPH.0000000000002170.

引用本文的文献

1
Prognostic Value of Caspase-3 and Cardiac Troponin I in Assessing Cardiovascular Risk in Pediatric COVID-19 and Multisystem Inflammatory Syndrome.半胱天冬酶-3和心肌肌钙蛋白I在评估儿童新冠病毒病和多系统炎症综合征心血管风险中的预后价值
J Multidiscip Healthc. 2025 May 30;18:3009-3019. doi: 10.2147/JMDH.S514776. eCollection 2025.
2
Prognostic Value of Fragmented QRS on Admission Electrocardiogram among Patients Hospitalized with COVID-19: A Single-Center Report, Systematic Review, and Meta-Analysis.COVID-19住院患者入院心电图碎裂QRS波的预后价值:单中心报告、系统评价和荟萃分析
Acta Cardiol Sin. 2025 May;41(3):323-334. doi: 10.6515/ACS.202505_41(3).20241111D.
3

本文引用的文献

1
Cardiovascular impact of COVID-19 with a focus on children: A systematic review.新冠病毒病对心血管系统的影响(聚焦于儿童):一项系统综述
World J Clin Cases. 2020 Nov 6;8(21):5250-5283. doi: 10.12998/wjcc.v8.i21.5250.
2
Assessment of Cardiac Arrhythmic Risk in Children With Covid-19 Infection.评估新冠病毒感染儿童的心律失常风险。
Pediatr Cardiol. 2021 Feb;42(2):264-268. doi: 10.1007/s00246-020-02474-0. Epub 2020 Oct 2.
3
COVID-19 and Hyperinflammatory Syndrome in Children: Kawasaki Disease with Macrophage Activation Syndrome in Disguise?
The Evaluation of Troponin I Levels and Myocarditis in Children with COVID-19: A Pediatric Single-Center Experience.
新型冠状病毒肺炎患儿肌钙蛋白 I 水平与心肌炎的评估:儿科单中心经验
Pediatr Cardiol. 2023 Apr;44(4):873-881. doi: 10.1007/s00246-022-03017-5. Epub 2022 Oct 9.
4
Ventricular repolarization heterogeneity in patients with COVID-19: Original data, systematic review, and meta-analysis.COVID-19 患者的心室复极异质性:原始数据、系统评价和荟萃分析。
Clin Cardiol. 2022 Jan;45(1):110-118. doi: 10.1002/clc.23767. Epub 2022 Jan 10.
儿童新冠病毒肺炎与高炎症综合征:伪装成巨噬细胞活化综合征的川崎病?
Cureus. 2020 Aug 1;12(8):e9515. doi: 10.7759/cureus.9515.
4
Coronavirus-induced myocarditis: A meta-summary of cases.冠状病毒性心肌炎:病例汇总分析。
Heart Lung. 2020 Nov-Dec;49(6):681-685. doi: 10.1016/j.hrtlng.2020.08.013. Epub 2020 Aug 20.
5
Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval.症状性儿科 SARS-CoV-2 感染 PCR 阳性患者心律失常和心电图异常的发生率,包括校正 QT 间期的药物诱导变化。
Heart Rhythm. 2020 Nov;17(11):1960-1966. doi: 10.1016/j.hrthm.2020.06.033. Epub 2020 Jul 1.
6
Cardiac Manifestations of Coronavirus Disease 2019 (COVID-19): A Comprehensive Review.2019年冠状病毒病(COVID-19)的心脏表现:全面综述
Cureus. 2020 May 8;12(5):e8021. doi: 10.7759/cureus.8021.
7
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort.儿童多系统炎症综合征与 SARS-CoV-2 相关,表现类似川崎病(川崎 COVID-19):一项多中心队列研究。
Ann Rheum Dis. 2020 Aug;79(8):999-1006. doi: 10.1136/annrheumdis-2020-217960. Epub 2020 Jun 11.
8
Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: findings and correlation with clinical outcome.新型冠状病毒病 2019(COVID-19)感染的胸部 X 线表现:特征与临床转归的相关性。
Radiol Med. 2020 Aug;125(8):730-737. doi: 10.1007/s11547-020-01232-9. Epub 2020 Jun 9.
9
Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review.儿童心脏与 COVID-19:以系统评价形式呈现的最新证据。
Eur J Pediatr. 2020 Jul;179(7):1079-1087. doi: 10.1007/s00431-020-03699-0. Epub 2020 May 30.
10
COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap!新型冠状病毒肺炎、心律失常风险与炎症:注意差距!
Circulation. 2020 Jul 7;142(1):7-9. doi: 10.1161/CIRCULATIONAHA.120.047293. Epub 2020 Apr 14.